Results

Total Results: 543 records

Showing results for "anticoagulant prophylaxis".

  1. effectivehealthcare.ahrq.gov/products/stroke-afib-update/research-protocol
    July 07, 2017 - Newer anticoagulants (direct oral anticoagulants [DOACs]) resulted in reduced stroke and bleeding events … Procedural interventions Procedural interventions for stroke prophylaxis have emerged and are growing … with AF are uncertain There is a lack of information to guide decisions regarding the best specific anticoagulant … Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism … pradaxa[tiab] OR heparin[tiab] OR apixaban[tiab] OR eliquis[tiab] OR edoxaban[tiab] OR lixiana[tiab] OR anticoagulant
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
    May 01, 2013 - Similarly, we included antiplatelet agents aspirin and clopidogrel; as well as the anticoagulant warfarin … We also included dabigatran, a recently approved oral anticoagulant that directly inhibits thrombin … A study of extended prophylaxis versus inpatient prophylaxis suggested that continuing enoxaparin therapy … Rare events such as bleeding from prophylactic doses of anticoagulant are difficult to answer in trials … Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
    May 01, 2013 - Similarly, we included antiplatelet agents aspirin and clopidogrel; as well as the anticoagulant warfarin … We also included dabigatran, a recently approved oral anticoagulant that directly inhibits thrombin … A study of extended prophylaxis versus inpatient prophylaxis suggested that continuing enoxaparin therapy … Rare events such as bleeding from prophylactic doses of anticoagulant are difficult to answer in trials … Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College
  4. ahrqpubs.ahrq.gov/research/findings/studies/index.html?page=4
    January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV. Am Fam Physician 2023 Dec; 108(6):617-18..
  5. healthcare411.ahrq.gov/research/findings/studies/index.html?page=4
    January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV. Am Fam Physician 2023 Dec; 108(6):617-18..
  6. cahps.ahrq.gov/research/findings/studies/index.html?page=4
    January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV. Am Fam Physician 2023 Dec; 108(6):617-18..
  7. monahrq.ahrq.gov/research/findings/studies/index.html?page=4
    January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV. Am Fam Physician 2023 Dec; 108(6):617-18..
  8. patientregistry.ahrq.gov/research/findings/studies/index.html?page=4
    January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV. Am Fam Physician 2023 Dec; 108(6):617-18..
  9. talkingquality.ahrq.gov/research/findings/studies/index.html?page=4
    January 01, 2024 - did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … The primary measure was anticoagulant-related CIMEs and non-anticoagulant-related CIMEs over 90 days … There was no reduction in anticoagulant-related CIMEs among intervention patients or non-anticoagulant-related … did not reduce clinically important medication errors for ambulatory patients initiating direct oral anticoagulants … Preexposure prophylaxis to prevent acquisition of HIV. Am Fam Physician 2023 Dec; 108(6):617-18..
  10. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/866995/psn-pdf
    October 30, 2024 - their response to unfractionated heparin—with some patients requiring large doses to achieve adequate prophylaxis … or activated factor X levels, has been proposed as a means to monitor the effectiveness of heparin prophylaxis … injured patients, ordering clinicians must carefully weigh the risks and benefits of pharmacologic prophylaxis … Early pharmacological venous thromboembolism prophylaxis is safe after operative fixation of traumatic
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
    October 27, 2017 - Newer anticoagulants (direct oral anticoagulants [DOACs]) resulted in reduced stroke and bleeding events … of studies have examined the appropriate populations and appropriate therapies for adequate stroke prophylaxis … Procedural interventions Procedural interventions for stroke prophylaxis have emerged and are growing … AF are uncertain • There is a lack of information to guide decisions regarding the best specific anticoagulant … Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
    October 27, 2017 - Newer anticoagulants (direct oral anticoagulants [DOACs]) resulted in reduced stroke and bleeding events … of studies have examined the appropriate populations and appropriate therapies for adequate stroke prophylaxis … Procedural interventions Procedural interventions for stroke prophylaxis have emerged and are growing … AF are uncertain • There is a lack of information to guide decisions regarding the best specific anticoagulant … Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism
  13. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49656/psn-pdf
    June 01, 2012 - Who is responsible for routine patient safety measures, such as deep venous thrombosis prophylaxis? … Because of the risk of central nervous system bleeding, anticoagulant use is a shared responsibility—hospitalists … always contact neurosurgery physicians before starting antiplatelet or anticoagulant agents.
  14. ce.effectivehealthcare.ahrq.gov/news/newsroom/case-studies/ktcquips98.html
    October 01, 2014 - As a result, prevalence of appropriate VTE prophylaxis increased from 55 to 100 percent for surgical … prophylaxis and 100 percent for patients admitted to the hospitalist service between March and August … As a result of these interventions, appropriate VTE prophylaxis increased from 0 to 100 percent, and … The dashboard appears in green if the patient is on pharmacological prophylaxis, in yellow if the patient … is on sequential compression devices or if a contraindication is documented, and in red if VTE prophylaxis
  15. digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/clinical-decision-support-system
    June 07, 2000 - Purpose of Study:  Determine whether presentation of venous thromboembolism prophylaxis guidelines using
  16. effectivehealthcare-admin.ahrq.gov/health-topics/carbohydrates?page=1
    May 29, 2013 - Products Systematic Review Archived May 29, 2013 Pharmacologic and Mechanical Prophylaxis … difficile Infection Systematic Review Archived March 13, 2012 Venous Thromboembolism Prophylaxis … Protocol Archived January 12, 2012 Comparative Effectiveness of Pharmacologic and Mechanical Prophylaxis … Protocol Archived August 6, 2010 Comparative Effectiveness of Venous Thromboembolism (VTE) Prophylaxis
  17. psnet.ahrq.gov/issue/automatic-detection-omissions-medication-lists
    December 31, 2014 - December 7, 2011 Modes of failure in venous thromboembolism prophylaxis. … December 16, 2020 WebM&M Cases Direct Oral Anticoagulants
  18. pbrn.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.
  19. pcmh.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.
  20. www.ahrq.gov/sites/default/files/2024-07/rothberg-report.pdf
    January 01, 2024 - rate of prophylaxis is high but the rate of inappropriate prophylaxis is also high. … Patients received enoxaparin 40 mg/day for prophylaxis. … any prophylaxis, adjusted for baseline risk of VTE. … In the base case, prophylaxis had an incremental cost of $44,091/QALY saved compared with no prophylaxis … An observational study of the effectiveness of VTE prophylaxis, comparing patients who received prophylaxis